<SEC-DOCUMENT>0001213900-26-043518-index.html : 20260414
<SEC-HEADER>0001213900-26-043518.hdr.sgml : 20260414
<ACCEPTANCE-DATETIME>20260414160101
ACCESSION NUMBER:		0001213900-26-043518
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20260414
FILED AS OF DATE:		20260414
DATE AS OF CHANGE:		20260414

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Clearmind Medicine Inc.
		CENTRAL INDEX KEY:			0001892500
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				000000000
		STATE OF INCORPORATION:			Z4
		FISCAL YEAR END:			1031

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-41557
		FILM NUMBER:		26860812

	BUSINESS ADDRESS:	
		STREET 1:		101-1220 WEST 6TH AVENUE
		CITY:			VANCOUVER, BRITISH COLUMBIA
		STATE:			Z4
		ZIP:			V6H1A5
		BUSINESS PHONE:		972-54-5704749

	MAIL ADDRESS:	
		STREET 1:		101-1220 WEST 6TH AVENUE
		CITY:			VANCOUVER, BRITISH COLUMBIA
		STATE:			Z4
		ZIP:			V6H1A5
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>ea0286336-6k_clearmind.htm
<DESCRIPTION>CURRENT REPORT
<TEXT>
Document 1 - file: ea0286336-6k_clearmind.htm

</DOCUMENT>
</SEC-DOCUMENT>